English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance
Jan 17, 2024 22:00 HKT
Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Jan 17, 2024 15:00 HKT
최신 분석에 따르면 미국의 바이오테크 기업 중 65%가 적절한 CRO파트너를 식별하는 데 어려움을 겪고 있습니다
Jan 17, 2024 09:00 HKT
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Jan 16, 2024 20:00 HKT
最新的分析显示,65%的美国生物技术公司在寻找合适的合同研究机构(CRO)合作伙伴方面面临困难
Jan 16, 2024 19:00 HKT
最新的分析顯示,65%的美國生技公司在尋找合適的合約研究機構(CRO)合作夥伴方面面臨困難
Jan 16, 2024 19:00 HKT
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
Jan 16, 2024 13:00 HKT
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
Jan 15, 2024 15:00 HKT
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
Jan 12, 2024 16:00 HKT
Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding
Jan 06, 2024 09:00 HKT
冠科美博在中国完成复发或难治性急性髓细胞白血病uproleselan药物的三期临床桥接研究入组
Jan 03, 2024 20:10 HKT
冠科美博在中國完成復發或難治性急性髓細胞白血病uproleselan藥物的三期臨床橋接研究入組
Jan 03, 2024 20:09 HKT
ChemPartner Unveils Highly Anticipated Biology Database
Dec 23, 2023 07:00 HKT
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Dec 22, 2023 09:00 HKT
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作
Dec 22, 2023 09:00 HKT
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作
Dec 22, 2023 09:00 HKT
欧康维视生物: OT-703获批于香港上市,为糖尿病性黄斑水肿患者治疗带来新选择
Dec 20, 2023 20:53 HKT
歐康維視生物: OT-703獲批於香港上市,為糖尿病性黃斑水腫患者治療帶來新選擇
Dec 20, 2023 20:52 HKT
Ocumension Therapeutics: The Approval Received For Marketing OT-703 In Hong Kong, A New Option For Patients With Diabetic Macular Edema
Dec 20, 2023 20:51 HKT
TANAKA Precious Metals beteiligt sich an "Global Vascular", einem medizinischen Venture-Unternehmen, das Stent-Abwurfsysteme für die Behandlung von Arteriosklerose in den unteren Extremitäten entwickelt
Dec 19, 2023 18:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: